Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.5722
+0.0222
+(4.04%)
At close: April 1 at 4:00:01 PM EDT
0.5749
+0.00
+(0.47%)
After hours: April 1 at 6:12:34 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
64,848
64,848
116,507
96,560
29,336.3231
Operating Income
-64,848
-64,848
-116,507
-96,560
-29,336.3231
Net Non Operating Interest Income Expense
2,691
2,691
1,523
90
-333.0629
Other Income Expense
2,774
2,774
-2,809
-105,530
-89,600.3551
Pretax Income
-59,383
-59,383
-117,793
-202,000
-119,269.7412
Tax Provision
120
120
298
266
--
Net Income Common Stockholders
-59,503
-59,503
-118,091
-202,266
-119,269.7412
Diluted NI Available to Com Stockholders
-59,503
-59,503
-118,091
-202,266
-119,269.7412
Basic EPS
-1.08
--
-2.10
-3.92
-2.21
Diluted EPS
-1.08
--
-2.10
-3.92
-2.21
Basic Average Shares
55,067
--
54,969.3100
52,272.9600
53,941.6750
Diluted Average Shares
55,067
--
54,969.3100
52,272.9600
53,941.6750
Total Operating Income as Reported
-62,074
-62,074
-119,316
-98,107
-30,270.0014
Total Expenses
64,848
64,848
116,507
96,560
29,336.3231
Net Income from Continuing & Discontinued Operation
-59,503
-59,503
-118,091
-202,266
-119,269.7412
Normalized Income
-61,774.2500
-61,774.2500
-115,753.3900
-126,031.3700
-29,669.3861
Interest Income
2,714
2,714
1,544
97
109.7455
Interest Expense
23
23
21
7
6.4286
Net Interest Income
2,691
2,691
1,523
90
-333.0629
EBIT
-59,360
-59,360
-117,772
-201,993
-119,263.3126
EBITDA
-58,372
-58,372
-116,741
-201,359
-119,042.4441
Reconciled Depreciation
988
988
1,031
634
220.8685
Net Income from Continuing Operation Net Minority Interest
-59,503
-59,503
-118,091
-202,266
-119,269.7412
Total Unusual Items Excluding Goodwill
2,875
2,875
-2,959
-104,431
-89,600.3551
Total Unusual Items
2,875
2,875
-2,959
-104,431
-89,600.3551
Normalized EBITDA
-61,247
-61,247
-113,782
-96,928
-29,442.0890
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
--
Tax Effect of Unusual Items
603.7500
603.7500
-621.3900
-28,196.3700
--
12/31/2020 - 3/19/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SILO Silo Pharma, Inc.
1.1300
-3.42%
ADAG Adagene Inc.
1.8150
+17.86%
PHGE BiomX Inc.
0.4930
-11.28%
THAR Tharimmune, Inc.
1.2800
-5.88%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.2700
-5.22%
EQ Equillium, Inc.
0.5038
+28.42%
NBTX Nanobiotix S.A.
3.5800
+1.13%
ACTU Actuate Therapeutics, Inc. Common stock
6.70
-1.03%
FBLG FibroBiologics, Inc.
0.8600
-4.44%
BCDA BioCardia, Inc.
2.1400
-15.75%